727 results on '"Sezer O"'
Search Results
152. Role of Interleukin 16 in Multiple Myeloma
153. Management der Polyneuropathie beim Multiplen Myelom unter der Therapie mit Bortezomib: Empfehlungen aus klinischen Erfahrungen
154. A phase lb study of oral panobinostat and IV bortezomib in relapsed or relapsed and refractory multiple myeloma.
155. An audit of seafood consumption awareness during pregnancy and its association with maternal and fetal outcomes in a Turkish population
156. Autorenverzeichnis
157. Discordant late onset lower urinary tract obstruction in a dizygotic twin pregnancy treated with vesicoamniotic shunt
158. ChemInform Abstract: Diazoaldehyde Chemistry. Part 4. Vilsmeier-Haack Formylation of Diazo Compounds: A Reinvestigation.
159. Phase Ib study of oral panobinostat (LBH589) plus intravenous bortezomib in patients (Pts) with relapsed (Rel) or Rel and refractory (Ref) multiple myeloma (MM).
160. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer
161. Der Einfluss von Bortezomib auf den Knochenstoffwechsel beim multiplen Myelom
162. Bortezomib, IV cyclophosphamide, and dexamethasone (VelCD) as induction therapy in newly diagnosed multiple myeloma: Results of an interim analysis of the German DSMM Xia trial
163. B381 Synergistic Action of Heat-Shock Protein—90 Inhibitor NVP-AUY922 with Histone Deacetylase Inhibition
164. B253 Serum DKK1 Levels in Multiple Myeloma
165. A339 The Bone Marker ICTP Adds to the Prognostic Significance of the ISS in Symptomatic Multiple Myeloma
166. A337 Panobinostat and Bortezomib Phase I Trial in Multiple Myeloma
167. Prevention of sternal dehiscence and infection in high-risk patients: A prospective randomised multicenter trial
168. Hypoxie bei soliden Tumoren
169. 489: Influence of LVAD Support in Pediatric Patients on Outcome during Transplant Waiting-Time
170. Reply to ‘Proteasome inhibition therapies in childhood cancer’ by Zaman et al.
171. Population Pharmacokinetics of Melphalan and Glutathione S-transferase Polymorphisms in Relation to Side Effects
172. Assessing quality of life in patients with colorectal cancer: An update of the EORTC quality of life questionnaire
173. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma
174. Bortezomib in combination with dexamethasone for patients with relapsed Hodgkin's lymphoma: results of a prematurely closed phase II study (NCT00148018)
175. Proteasome as an Emerging Therapeutic Target in Cancer
176. A Self-Adjusting Simple Hyperstable Adaptive Recursive Algorithm
177. Determinants of patient satisfaction in oncology settings from European and Asian countries: Preliminary results based on the EORTC IN-PATSAT32 questionnaire
178. The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation
179. Interdisziplinäre Leitlinien zur Diagnostik und Therapie der extrazerebralen Amyloidosen
180. An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)
181. Pharmacokinetics of melphalan and genotypes of glutathione S-transferases GSTM1 and GSTT1 and correlation to adverse effects
182. Adaptive autoregressive model for the analysis of center of pressure in healthy subjects during quiet standing
183. A Bioinspired in vitro Lung Model to Study Particokinetics of Nano-/Microparticles Under Cyclic Stretch and Air-Liquid Interface Conditions
184. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer
185. Comparison of combination of 3- in-1 block and sciatic nerve block or remifentanil infusion in knee arthroscopy
186. Complete Remission with Long-Term Survival in a Patient with Esophageal Carcinoma and a Tracheoesophageal Fistula after Treatment with the AIO Regimen and Bi-Weekly Cisplatin
187. Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer
188. Better computer vision under video compression, an example using mean shift tracking.
189. Prediction of Response to Hormonal Treatment in Metastatic Breast Cancer
190. Adaptive IIR constrained LMS algorithm for multiple narrowband interference rejection.
191. Constrained RLS algorithm for narrow band interference rejection from EEG signal during CES.
192. Venenkatheter-assoziierte Infektionen bei Patienten mit Neutropenie
193. Therapie von Pilzinfektionen in der Hämatologie und Onkologie
194. Mucormycoses
195. Documented infections with neutropenia: therapeutic and diagnostic recommendations
196. Detection of HMGI-C in the peripheral blood of breast cancer patients
197. Prediction of influenza antibody titer following vaccination by CD4/CD8 ratio
198. Comparison of the evaluation of the subjective quality of life in cancer patients by themselves and by their physicians
199. Evaluation of drug resistance mechanisms in mast cell leukemia
200. EWS-FLI1 gene rearrangement and CD99 positivity identify a breast tumor as a PNET
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.